Current Medical Developments on HIV-AIDS

Euro HIV Meet 2020 welcomes all the professionals from Medical Healthcare, Physicians, Medicine Specialists, Professors, Medical Researchers, Nurses and Nurse Practitioners, Fellow Scholars, Industrial Professionals, and Students to our 2-day event “European Summit on HIV, STD and STIs” scheduled on August 19-20, 2020 at Milan, Italy.

The conference offers emerging scholar awards to outstanding researchers, exceptional graduates or early academicians who have distinctive enthrallment towards the conference themes. The Award strives in providing a strong professional development opportunity for early career academicians including; meeting experts in the field, interacting with colleagues from different countries, and creating networks and long-term relations.

The main objective of the Conference is to provide a platform for all the medical professionals including students to discuss and learn the new innovations on infectious disease research, clinical updates and new discoveries with the viruses and industrial experts to advance the ongoing research. The conference will highlight on different topics such as- Epidemiology of HIV AIDS & Infectious Diseases; HIV/AIDS Nursing Care Management; Awareness & Information on HIV-AIDS, STDs, and STIs; Viral, Bacterial, Fungal & Protozoan STDs; HIV Aging and Bone Damage; AIDS Stigma and Discrimination; HIV and Cancer: Risks, Types & Treatment; HIV, Viral hepatitis, and Tuberculosis.

Conference Opportunities for Researchers and Faculty Members:

• Speaker Presentations
• Poster Display
• Symposium hosting (4-5-member team)
• Workshop organizing
• Association Partnering
• Collaboration proposals
• Academic Partnering
• Group Participation
• For Students and Research Scholars:
• Poster Competition (Winner will get Best Poster Award)
• Young Researcher Forum (YRF Award to the best presenter)
• Group registrations
• Book Launch event
• Networking opportunities
• Exhibitor and Vendor booths
• Sponsorships opportunities

Market Report:

Human immunodeficiency virus (HIV) is one of the most infectious diseases with around 36.7 million people suffering by the end of 2015, according to The Joint United Nations Programme on HIV/AIDS (UNAIDS). Global HIV Drug Market was valued at $20,448 million in 2015 and is expected to garner $26,458 million by 2022. In 2017 the global HIV drugs market exceeded a value of US$ 17 Billion. Looking forward, the market value is expected to reach nearly US$ 21 Billion by 2023, expanding at a CAGR of more than 3% during 2018-2023.

Antiretroviral therapy (ART) is recommended to treat HIV infection. People on ART take a combination of HIV medications every day. ART can’t cure HIV infection, but HIV medicines help individuals with HIV live longer, healthier lives. HIV medicines can also decrease the risk of HIV transmission. HIV diagnostics market size was valued at USD 2.9 billion in 2017 and is expected to witness 8.7% CAGR from 2018 to 2024.

Increasing the prevalence of HIV infection worldwide will majorly boost HIV diagnostics market growth over the forecast period. HIV infection is one of the leading causes of morbidity and mortality. As per the UNAIDS’s data, more than 36.7 million people across the globe were living with HIV in 2017. Around 1.8 million children aged below 15 years had HIV infection. Additionally, many were infected by their HIV-positive mothers during pregnancy, childbirth or breast-feeding. Growing incidences of AIDS, especially in the developing and underdeveloped economies, will offer several growth opportunities in HIV diagnostics resulting in industry growth.

Contact:

Emma Green | Program Manager

Euro HIV Meet 2020

P: +44 1875240007

Email: hiv@euromedicalmeetings.org